Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027885
Status:
COMPLETED
Last Update Posted:
2013-06-17
First Post:
2001-12-07
Brief Title:
Phase II Bevacizumab Tax In Advanced Breast Cancer
Sponsor:
Organization:
Case Comprehensive Cancer Center